
We read with great interest the article by Goldberg et al1 reporting the results of a “Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal Cancer” published in the September 1, 2006, issue of the Journal of Clinical Oncology. The elderly population represents a heterogeneous group of patients frequently undertreated due to their age, although benefits of therapy could be overlapped with their younger counterpart.
Aged, 80 and over, Chronotherapy, Male, Dose-Response Relationship, Drug, Organoplatinum Compounds, Age Factors, Leucovorin, Prognosis, Survival Analysis, Oxaliplatin, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Fluorouracil, Colorectal Neoplasms, Geriatric Assessment, Aged
Aged, 80 and over, Chronotherapy, Male, Dose-Response Relationship, Drug, Organoplatinum Compounds, Age Factors, Leucovorin, Prognosis, Survival Analysis, Oxaliplatin, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Fluorouracil, Colorectal Neoplasms, Geriatric Assessment, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
